Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117405) titled 'Study Comparing Different Pembrolizumab Treatment Schedules with Chemotherapy in Advanced Lung Cancer' on Sept. 10.
Study Type: Interventional
Study Design:
Randomized, Parallel Group, Multiple Arm Trial Method of generating randomization sequence:Stratified block randomization Method of allocation concealment:Other Blinding and masking:Open Label
Primary Sponsor: Tata Memorial Hospital
Condition:
Health Condition 1: C399- Malignant neoplasm of lower respiratory tract, part unspecified
Intervention:
Intervention1: Pembrolizumab reduced frequency: Pembrolizumab will be administered at a reduced freq...